Skip to main content Skip to main navigation menu Skip to site footer
Rheumatology Reports

eISSN 2036-752X

  • Archives
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Cartilage integrity and proteoglycan turnover are comparable in canine experimentally induced and human joint degeneration

    Femke Intema, Simon Mastbergen, Cees van Rinsum, Rene Castelein, Anne Karien Marijnissen, Johannes Bijlsma, Floris Lafeber
    e7
    15-10-2010
    https://doi.org/10.4081/rr.2010.e7
    1242
    PDF: 557
    HTML: 1404
  • Biomarkers of outcome in rheumatoid arthritis

    Roberto Carrasco, Anne Barton
    e3
    02-09-2010
    https://doi.org/10.4081/rr.2010.e3
    7638
    PDF: 906
    HTML: 21694
  • Role of calcitonin in management of musculoskeletal pain

    Lars Arendt-Nielsen, Hans Christian Hoeck, Morten A Karsdal, Claus Christiansen
    e12
    10-12-2009
    https://doi.org/10.4081/rr.2009.e12
    1733
    PDF: 882
    HTML: 3135
  • Iguratimod (T-614): A novel disease modifying anti-rheumatic drug

    Keiichi Tanaka
    e4
    23-07-2009
    https://doi.org/10.4081/rr.2009.e4
    5007
    PDF: 1337
    HTML: 35015
  • Serum sodium/potassium ratio in patients with rheumatoid arthritis and osteoarthritis

    Alexander P. Rozin, Josef Pruzansky, Yeouda Edoute, Alexandra Balbir-Gurman
    e5
    13-07-2010
    https://doi.org/10.4081/rr.2010.e5
    3965
    PDF: 754
    HTML: 2834
1 - 5 of 5 items
  • Genetic predictors of response to anti-tumor necrosis factor drugs in rheumatoid arthritis
    17
  • Tumor necrosis factor-alpha inhibitor combined with methotrexate for ankylosing spondylitis: a systematic review and meta-analysis
    14
  • A qualitative study on patients with knee osteoarthritis to evaluate the influence of different pain patterns on patients’ quality of life and to find out patients’ interpretation and coping strategies for the disease
    12
  • Successful treatment of neuro-Behçet’s disease with infliximab: four years follow-up
    11
  • Iguratimod (T-614): A novel disease modifying anti-rheumatic drug
    9

Keywords

Rheumatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 2036-7511
eISSN: 2036-752X

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy